MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$3,505,000
EPS
$0.07
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-09-30
2025-06-30
Revenues
0
0
0
Cost of revenue
0
0
0
Gross profit
0
0
0
Research and development expense
2,251,000
1,643,000
1,520,000
General and administrative expense
1,288,000
1,613,000
1,148,000
Net expenses related to opko collaboration agreement
3,539,000
3,256,000
2,668,000
Operating loss
-3,539,000
-3,256,000
-2,668,000
Financial (income) expenses, net
34,000
56,000
12,000
Net loss
-3,505,000
-3,200,000
-2,656,000
Basic EPS
0.07
0.07
0.06
Diluted EPS
0.07
0.07
0.06
Basic Average Shares
47,756,409
47,089,814
46,836,700
Diluted Average Shares
47,756,409
47,089,814
46,836,700
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$3,505,000
Financial (income)
expenses, net
$34,000
Operating loss
-$3,539,000
Net expenses
related to opko...
$3,539,000
Research and development
expense
$2,251,000
General and
administrative expense
$1,288,000
Buy us a coffee
Entera Bio Ltd. (ENTXW)
Entera Bio Ltd. (ENTXW)